台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    93.3
  • 漲跌
    ▼0.7
  • 漲幅
    -0.74%
  • 成交量
    251
  • 產業
    上櫃 生技醫療類股
  • 303人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-永豐金-三民 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-三民 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/05/1000.003100.50100.00-3806-0.37%
2019/04/180.1106.5000.00107.000.18220.01%
2019/04/1700.002108.50108.00-2832-0.24%
2019/04/122112.5000.00109.5028430.24%
2019/03/2500.003109.50108.00-3742-0.40%
2019/03/1400.004113.00113.50-4735-0.54%
2019/03/071117.5000.00116.5017080.14%
2019/03/061110.0000.00114.0016480.15%
2019/03/052112.500.1108.00108.0026030.32%
2019/03/040.7108.0010105.95108.50-9.3544-1.71%
2019/02/2510104.5000.00103.50105291.89%
2019/02/221106.0000.00105.5015340.19%
2019/02/181105.0000.00105.0015120.20%
2019/02/1500.008107.50105.50-8504-1.59%
2019/02/138103.0000.00103.0084841.65%
2019/01/2200.001104.00104.00-1597-0.17%
2019/01/161100.501102.50102.5006190.00%
2019/01/140.3109.5000.00109.500.35990.05%
2019/01/031111.0000.00110.0016220.16%
2018/12/201111.5000.00112.0017080.14%
2018/12/131119.0000.00118.0017120.14%
2018/12/071107.001110.00115.0007070.00%
2018/12/0500.001111.50112.00-1699-0.14%
2018/11/291.6105.881107.00107.000.66750.09%
2018/11/211104.5000.00103.0016680.15%
2018/11/070.3105.0000.00105.000.36960.04%
2018/11/021102.0000.00102.0016730.15%
2018/11/010.1101.0000.00100.500.16640.01%
2018/10/3000.001106.50103.50-1670-0.15%
2018/10/251113.0000.00112.5017110.14%
2018/10/220.1119.5000.00119.500.17190.01%
2018/10/1500.001122.00121.00-1768-0.13%
2018/10/111114.0000.00114.5018170.12%
2018/10/081132.001129.50129.0008450.00%
2018/10/0500.001130.00130.50-1977-0.10%
2018/10/041131.001134.50132.0009770.00%
2018/09/2800.002128.75129.00-2988-0.20%
2018/09/201127.0000.00124.0011,0340.10%
2018/09/181125.5000.00126.0011,0470.10%
2018/09/1400.002130.00130.00-21,122-0.18%
2018/09/1300.001131.00129.50-11,186-0.08%
2018/09/111123.5000.00123.5011,2000.08%
2018/09/071126.5000.00125.5011,2240.08%
2018/08/311135.002134.50134.00-11,317-0.08%
2018/08/281133.0000.00133.0011,4090.07%
2018/08/1600.001136.00137.50-11,528-0.07%
2018/08/131131.0000.00132.5011,5070.07%
2018/07/301135.501.4135.70135.00-0.41,408-0.03%
2018/07/271139.0000.00138.5011,4130.07%
2018/07/241133.502137.25138.00-11,418-0.07%
2018/07/231132.5000.00131.5011,4060.07%
2018/07/163147.6700.00146.5031,3280.23%
2018/07/092135.001132.00132.0011,1720.09%
2018/07/061125.5000.00128.0011,1650.09%
2018/06/212139.5000.00139.0021,0720.19%
2018/06/201138.0000.00140.0011,0750.09%
2018/06/132147.0000.00145.0021,0390.19%
2018/06/0800.001150.00149.50-11,036-0.10%
2018/05/251127.501128.50128.5008260.00%
2018/05/171129.0000.00127.5018730.11%
2018/04/181144.0000.00147.0018650.12%
2018/03/3100.001142.50143.50-1792-0.13%
2018/03/291144.501144.00144.0007880.00%
2018/03/1600.001145.50144.50-1731-0.14%
2018/03/141139.001137.50139.0007250.00%
2018/03/071135.001135.50132.5007790.00%
2018/02/081129.0000.00129.5017770.13%
2018/02/0600.001138.00129.00-1780-0.13%
2018/02/0500.002138.75142.00-2762-0.26%
2018/01/3100.001145.50147.00-1790-0.13%
2018/01/241151.5000.00151.0018030.12%
2018/01/233151.6700.00150.5038050.37%
2018/01/164158.133155.50154.5019490.11%
2018/01/1000.001150.00149.50-1905-0.11%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章